Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 39 articles:
HTML format
Text format



Single Articles


    April 2019
  1. DEN HOLLANDER WJ, Holster IL, den Hoed CM, Capelle LG, et al
    Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions.
    Gut. 2019;68:585-593.
    PubMed     Text format     Abstract available


    March 2019
  2. CAI Q, Zhu C, Yuan Y, Feng Q, et al
    Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study.
    Gut. 2019 Mar 29. pii: gutjnl-2018-317556. doi: 10.1136/gutjnl-2018-317556.
    PubMed     Text format     Abstract available


  3. WANG P, Wang Y, Langley SA, Zhou YX, et al
    Diverse tumour susceptibility in Collaborative Cross mice: identification of a new mouse model for human gastric tumourigenesis.
    Gut. 2019 Mar 6. pii: gutjnl-2018-316691. doi: 10.1136/gutjnl-2018-316691.
    PubMed     Text format     Abstract available


    January 2019
  4. LIN C, He H, Liu H, Li R, et al
    Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer.
    Gut. 2019 Jan 19. pii: gutjnl-2018-316324. doi: 10.1136/gutjnl-2018-316324.
    PubMed     Text format     Abstract available


  5. RAHN S, Kruger S, Rocken C, Helm O, et al
    Response to: 'Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma'.
    Gut. 2019;68:179-180.
    PubMed     Text format    


    September 2018
  6. WANG DS, Liu ZX, Lu YX, Bao H, et al
    Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer.
    Gut. 2018 Sep 29. pii: gutjnl-2018-316522. doi: 10.1136/gutjnl-2018-316522.
    PubMed     Text format     Abstract available


    July 2018
  7. MOAYYEDI P, Veldhuyzen van Zanten SJO, Hookey L, Armstrong D, et al
    Proton pump inhibitors and gastric cancer: association is not causation.
    Gut. 2018 Jul 13. pii: gutjnl-2018-316958. doi: 10.1136/gutjnl-2018-316958.
    PubMed     Text format    


    May 2018
  8. KOBAYASHI J, Uchida H, Ito J
    Long-term proton pump inhibitor use after Helicobacter pylori eradication may create a gastric environment for N-nitrosamine formation and gastric cancer development.
    Gut. 2018 May 25. pii: gutjnl-2018-316592. doi: 10.1136/gutjnl-2018-316592.
    PubMed     Text format    


    April 2018
  9. SEIDLITZ T, Merker SR, Rothe A, Zakrzewski F, et al
    Human gastric cancer modelling using organoids.
    Gut. 2018 Apr 27. pii: gutjnl-2017-314549. doi: 10.1136/gutjnl-2017-314549.
    PubMed     Text format     Abstract available


  10. LAI SW, Lai HC, Lin CL, Liao KF, et al
    Proton pump inhibitors and risk of gastric cancer in a case-control study.
    Gut. 2018 Apr 16. pii: gutjnl-2018-316371. doi: 10.1136/gutjnl-2018-316371.
    PubMed     Text format    


  11. WAN QY, Wu XT, Li N, Du L, et al
    Long-term proton pump inhibitors use and risk of gastric cancer: a meta-analysis of 926 386 participants.
    Gut. 2018 Apr 3. pii: gutjnl-2018-316416. doi: 10.1136/gutjnl-2018-316416.
    PubMed     Text format    


    March 2018
  12. COOK MB, Coburn SB, Lam JR, Taylor PR, et al
    Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort.
    Gut. 2018;67:418-529.
    PubMed     Text format     Abstract available


    February 2018
  13. PENG YC, Huang LR, Lin CL, Hsu WY, et al
    Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD.
    Gut. 2018 Feb 22. pii: gutjnl-2018-316057. doi: 10.1136/gutjnl-2018-316057.
    PubMed     Text format    


  14. FERREIRA RM, Pereira-Marques J, Pinto-Ribeiro I, Costa JL, et al
    Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota.
    Gut. 2018;67:226-236.
    PubMed     Text format     Abstract available


    January 2018
  15. DOORAKKERS E, Lagergren J, Engstrand L, Brusselaers N, et al
    Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population.
    Gut. 2018 Jan 30. pii: gutjnl-2017-315363. doi: 10.1136/gutjnl-2017-315363.
    PubMed     Text format     Abstract available


  16. LATERZA L, Scaldaferri F, Gasbarrini A
    Risk factors for gastric cancer: is it time to discard PPIs?
    Gut. 2018 Jan 13. pii: gutjnl-2017-315621. doi: 10.1136/gutjnl-2017-315621.
    PubMed     Text format    


  17. RUGGE M, Meggio A, Pravadelli C, Barbareschi M, et al
    Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients.
    Gut. 2018 Jan 6. pii: gutjnl-2017-314600. doi: 10.1136/gutjnl-2017-314600.
    PubMed     Text format     Abstract available


  18. SUISSA S, Suissa A
    Proton-pump inhibitors and increased gastric cancer risk: time-related biases.
    Gut. 2018 Jan 3. pii: gutjnl-2017-315729. doi: 10.1136/gutjnl-2017-315729.
    PubMed     Text format    


    December 2017
  19. NIIKURA R, Hayakawa Y, Hirata Y, Yamada A, et al
    Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis.
    Gut. 2017 Dec 22. pii: gutjnl-2017-315710. doi: 10.1136/gutjnl-2017-315710.
    PubMed     Text format    


  20. SUZUKI H, Matsuzaki J
    Helicobacter pylori eradication failure may have confounded the recent large-scale health database study that showed proton pump inhibitors increase gastric cancer risk.
    Gut. 2017 Dec 15. pii: gutjnl-2017-315698. doi: 10.1136/gutjnl-2017-315698.
    PubMed     Text format    


    November 2017
  21. GUETA I, Halkin H, Markovits N, Loebstein R, et al
    Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B 12.
    Gut. 2017 Nov 28. pii: gutjnl-2017-315695. doi: 10.1136/gutjnl-2017-315695.
    PubMed     Text format    


  22. WALDUM HL, Fossmark R
    Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man.
    Gut. 2017 Nov 20. pii: gutjnl-2017-315629. doi: 10.1136/gutjnl-2017-315629.
    PubMed     Text format    



  23. Erratum: Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids.
    Gut. 2017;66:2012.
    PubMed     Text format    


    October 2017
  24. CHEUNG KS, Chan EW, Wong AYS, Chen L, et al
    Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study.
    Gut. 2017 Oct 31. pii: gutjnl-2017-314605. doi: 10.1136/gutjnl-2017-314605.
    PubMed     Text format     Abstract available


    September 2017
  25. CHEN IF, Liu KW, Tang TQ, Wang WL, et al
    An unusual gastric tumour with gastric outlet obstruction.
    Gut. 2017 Sep 28. pii: gutjnl-2017-315087. doi: 10.1136/gutjnl-2017-315087.
    PubMed     Text format    


  26. YAN C, Zhu M, Huang T, Yu F, et al
    Genome-wide association studies identified loci contribute to phenotypic variance of gastric cancer.
    Gut. 2017 Sep 22. pii: gutjnl-2017-315230. doi: 10.1136/gutjnl-2017-315230.
    PubMed     Text format    


  27. NOTO JM, Chopra A, Loh JT, Romero-Gallo J, et al
    Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments.
    Gut. 2017 Sep 18. pii: gutjnl-2017-313863. doi: 10.1136/gutjnl-2017-313863.
    PubMed     Text format     Abstract available


    August 2017
  28. RAJENDRAN S, Benna C, Monticelli H, Spiro G, et al
    Germline variation of circadian pathway genes and prognosis of gastric cancer patients.
    Gut. 2017 Aug 8. pii: gutjnl-2017-314740. doi: 10.1136/gutjnl-2017-314740.
    PubMed     Text format    


  29. COKER OO, Dai Z, Nie Y, Zhao G, et al
    Mucosal microbiome dysbiosis in gastric carcinogenesis.
    Gut. 2017 Aug 1. pii: gutjnl-2017-314281. doi: 10.1136/gutjnl-2017-314281.
    PubMed     Text format     Abstract available


    June 2017
  30. HUANG LY, Wang X, Cui XF, Li H, et al
    IRTKS is correlated with progression and survival time of patients with gastric cancer.
    Gut. 2017 Jun 24. pii: gutjnl-2016-313478. doi: 10.1136/gutjnl-2016-313478.
    PubMed     Text format     Abstract available


  31. MERA RM, Bravo LE, Camargo MC, Bravo JC, et al
    Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial.
    Gut. 2017 Jun 24. pii: gutjnl-2016-311685. doi: 10.1136/gutjnl-2016-311685.
    PubMed     Text format     Abstract available


    May 2017
  32. SIERRA JC, Asim M, Verriere TG, Piazuelo MB, et al
    Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis.
    Gut. 2017 May 4. pii: gutjnl-2016-312888. doi: 10.1136/gutjnl-2016-312888.
    PubMed     Text format     Abstract available


  33. THOMPSON ED, Zahurak M, Murphy A, Cornish T, et al
    Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma.
    Gut. 2017;66:794-801.
    PubMed     Text format     Abstract available


    April 2017
  34. WANG Z, Dai J, Hu N, Miao X, et al
    Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies.
    Gut. 2017;66:581-587.
    PubMed     Text format     Abstract available


    March 2017
  35. ZHANG X, Xu W
    Neutrophils diminish T-cell immunity to foster gastric cancer progression: the role of GM-CSF/PD-L1/PD-1 signalling pathway.
    Gut. 2017 Mar 27. pii: gutjnl-2017-313923. doi: 10.1136/gutjnl-2017-313923.
    PubMed     Text format    


  36. WANG TT, Zhao YL, Peng LS, Chen N, et al
    Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway.
    Gut. 2017 Mar 8. pii: gutjnl-2016-313075. doi: 10.1136/gutjnl-2016-313075.
    PubMed     Text format     Abstract available


    December 2016
  37. MAEDA M, Nakajima T, Oda I, Shimazu T, et al
    High impact of methylation accumulation on metachronous gastric cancer: 5-year follow-up of a multicentre prospective cohort study.
    Gut. 2016 Dec 21. pii: gutjnl-2016-313387. doi: 10.1136/gutjnl-2016-313387.
    PubMed     Text format    


    October 2016
  38. MALFERTHEINER P, Megraud F, O'Morain CA, Gisbert JP, et al
    Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
    Gut. 2016 Oct 5. pii: gutjnl-2016-312288. doi: 10.1136/gutjnl-2016-312288.
    PubMed     Text format     Abstract available


    September 2016
  39. ZHU S, Soutto M, Chen Z, Peng D, et al
    Helicobacter pylori-induced cell death is counteracted by NF-kappaB-mediated transcription of DARPP-32.
    Gut. 2016 Sep 2. pii: gutjnl-2016-312141. doi: 10.1136/gutjnl-2016-312141.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: